Leukemia and Lymphoma

The AJMC® Leukemia & Lymphoma compendium is a comprehensive resource for clinical news and expert insights for the blood cancers and their treatments.

Latest News

Additional Results From POLARIX Study Show Improved PFS With No Reduction in HRQOL
Additional Results From POLARIX Study Show Improved PFS With No Reduction in HRQOL

January 29th 2023

New data from the POLARIX STUDY show that substituting polatuzumab vedotin for 1 part of a classic first-line chemotherapy combination to manage diffuse large B-cell lymphoma improved progression-free survival without compromising health-related quality-of-life.

PolaR-ICE Effective as Second-line Treatment in DLBCL, Bridge to Autologous Stem Cell Transplant
PolaR-ICE Effective as Second-line Treatment in DLBCL, Bridge to Autologous Stem Cell Transplant

January 28th 2023

Examining Safety, Efficacy of Pirtobrutinib in CLL/SLL, MCL, and WM; Results Seen for Patients With Intolerance to Covalent BTK Inhibitors
Examining Safety, Efficacy of Pirtobrutinib in CLL/SLL, MCL, and WM; Results Seen for Patients With Intolerance to Covalent BTK Inhibitors

January 27th 2023

Researchers Form Novel Database of Leukemia Transcriptome Profiles
Researchers Form Novel Database of Leukemia Transcriptome Profiles

January 20th 2023

FDA Gives Zanubrutinib Approval for First-line, R/R CLL/SLL
FDA Gives Zanubrutinib Approval for First-line, R/R CLL/SLL

January 19th 2023

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences
AJMC®
All rights reserved.